...
首页> 外文期刊>Advances in Experimental Medicine and Biology >Analysis of Neuroprotection by Taurine and Taurine Combinations in Primary Neuronal Cultures and in Neuronal Cell Lines Exposed to Glutamate Excitotoxicity and to Hypoxia/Re-oxygenation
【24h】

Analysis of Neuroprotection by Taurine and Taurine Combinations in Primary Neuronal Cultures and in Neuronal Cell Lines Exposed to Glutamate Excitotoxicity and to Hypoxia/Re-oxygenation

机译:原发性神经元培养中牛磺酸和牛磺酸组合的神经保护分析及暴露于谷氨酸兴奋毒性的神经元细胞系和缺氧/重氧化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ischemic stroke is one of the greatest contributors to death and long term disability in developed countries. Ischemia induced brain injury arises due to excessive release of glutamate and involves cell death due to apoptosis and endoplasmic reticulum (ER) stress responses. Despite major research efforts there are currently no effective treatments for stroke. Taurine, a free amino acid found in high concentrations in many invertebrate and vertebrate systems can provide protection against a range of neurological disorders. Here we demonstrate that taurine can combat ER stress responses induced by glutamate or by hypoxia/re-oxygenation in neuronal cell lines and primary neuronal cultures. Taurine decreased expression of ER stress markers GRP78, CHOP, Bim and caspase 12 in primary neuronal cultures exposed to hypoxia/re-oxygenation. In analyzing individual ER stress pathways we demonstrated that taurine treatment can result in reduced levels of cleaved ATF6 and decreased p-IRE1 levels. We hypothesized that because of the complex nature of stroke a combination therapy approach may be optimal. For this reason we proceeded to test combination therapies using taurine plus low dose administration of an additional drug: either granulocyte colony stimulating factor (G-CSF) or sulindac a non-steroidal anti-inflammatory drug with potent protective functions through signaling via ischemic preconditioning pathways. When primary neurons were pre-treated with 25 mM taurine and 25 ng/mL G-CSF for I hour and then exposed to high levels of glutamate, the taurine/G-CSF combination increased the protective effect against glutamate toxicity to 88% cell survival compared to 75% cell survival from an individual treatment with taurine or G-CSF alone. Pre-exposure of PC12 cells to 5 mM taurine or 25 mu M sulindac did not protect the cells from hypoxia/re-oxygenation stress whereas at these concentrations the combination of taurine plus sulindac provided significant protection. In summary we have demonstrated the protective effect of taurine in primary neuronal cultures against hypoxia with re-oxygenation through inhibition of ATF6 or p-IRE-1 pathway but not the PERK pathway of ER stress. Furthermore the combinations of taurine plus an additional drug (either G-CSF or sulindac) can show enhanced potency for protecting PC 12 cells from glutamate toxicity or hypoxia/re-oxygenation through inhibition of ER stress responses.
机译:缺血性中风是发达国家死亡和长期残疾的最大贡献者之一。由于谷氨酸过度释放,缺血诱导的脑损伤产生,并且由于细胞凋亡和内质网(ER)应激反应而涉及细胞死亡。尽管重大研究努力,目前目前没有有效的卒中治疗方法。牛磺酸,在许多无脊椎动物和脊椎动物系统中以高浓度发现的游离氨基酸可以提供针对一系列神经疾病的保护。在这里,我们证明牛磺酸可以打击谷氨酸诱导的ER应激反应或神经细胞系中的缺氧/再氧合和原发性神经元培养物。牛磺酸在原发性神经元培养物中暴露于缺氧/再氧化的原发性神经元培养物中的表达降低了ER应激标记物GRP78,Chec,Bim和Caspase 12的表达。在分析个体ER应激途径时,我们证明牛磺酸治疗可导致切割的ATF6水平降低和降低的P-IRE1水平。我们假设由于中风的复杂性,组合治疗方法可能是最佳的。由于这个原因,我们前进使用牛磺酸加低剂量给药的组合疗法另外的药物:粒细胞菌落刺激因子(G-CSF)或舒林蛋白是一种非甾体抗炎药,通过通过缺血预处理途径信号传导通过信号传导。当原发性神经元用25mm牛磺酸和25ng / ml G-CSF预处理时,然后暴露于高水平的谷氨酸,牛磺酸/ G-CSF组合增加了对88%的细胞存活率的保护作用与单独用牛磺酸或G-CSF的个体治疗中的75%的细胞存活率相比。 PC12细胞的预暴露至5mm牛磺酸或25μm舒林蛋白不保护细胞免受缺氧/再氧化应力的影响,而在这些浓度下,牛磺酸加舒林酸的组合提供了显着的保护。总之,我们已经证明了牛磺酸在原发性神经元培养物中对缺氧的保护作用,通过抑制ATF6或P-IRE-1途径,但不是ER应激的PERK途径。此外,牛磺酸的组合加上另外的药物(G-CSF或舒林蛋白)可以通过抑制ER应激反应来显示通过抑制ER应激响应来保护PC 12细胞免受谷氨酸毒性或缺氧/重新氧化的增强效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号